User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 8 results.
    • Speech
    Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer: Preliminary analysis of the PePiTA study.
    Hendlisz, Alain Caparica, Rafael Deleporte, Amélie Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Deboever, Guido Janssens, Jozef Demolin, Gauthier Holbrechts, Stephane Clausse, Marylene De Grez, Thierry Vermeij, Joanna D'Hondt, Lionel A. Geboes, Karen Paula Besse-Hammer, Tatiana Buggenhout, Alexis Paesmans, Marianne Piccart, Martine Flamen, Patrick (2019) 2019 ASCO Annual Meeting I - GASTROINTESTINAL (COLORECTAL) CANCER —
    • Speech
    Prognostic value of baseline and early changes of circulating-free (cf) and circulating tumor (ct) DNA in the neoadjuvant (NA) setting of early stage colon cancer (CC).
    Bregni, Giacomo Senti, Chiara Vandeputte, Caroline Acedo Reina, Elena Gkolfakis, Paraskevas Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Janssens, Jos Demolin, Gauthier Holbrechts, Stephane Clausse, Marylene De Grez, Thierry D'Hondt, Lionel A. Geboes, Karen Paula Besse-Hammer, Tatiana Rothe, Francoise Flamen, Patrick Hendlisz, Alain Sclafani, Francesco (2021) 2021 ASCO Annual Meeting I —
    • Speech
    Preoperative (preop) chemosensitivity Testing as predictor of treatment benefit in adjuvant stade III colon cancer (CC) : Interim analysis of the PEPITA study
    Hendlisz, Alain Deleporte, Amélie Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Deboever, Guido Janssens, Jos Demolin, Gauthier Holbrechts, Stéphane Clausse, Marylene Vermeij, Joanna D'Hondt, Lionel[UCL] Laurent, Stéphanie Efira, André Gomez Galdon, Maria Buggenhout , Alesxis Garcia, Camilo Piccart-Gebhart, Martine J Flamen, Patrick Belgian Group for Digestive Oncology (BGDO) (2014) 2014 ASCO GI Meeting — (United States) San Francisco, CA
    • Speech
    Preop chemosensitivity testing as predictor of adjuvant benefit in stage III colon cancer (PEPITA)
    Hendlisz, Alain Deleporte, Amélie Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Deboever, Guido Janssens, Jos Demolin, Gauthier Holbrechts, Stéphane Clausse, Marylene Vermeij, Joanna D'Hondt, Lionel[UCL] Laurent, Stéphanie Efira, André Peeters, Marc Gomez Galdon, Maria Buggenhout , Alexis Paesmans, Marianne Garcia, Camilo Piccart-Gebhart, Martine J Flamen, Patrick (2014) Belgian Week of Gastroenterology - XXVIth Edition — (Belgium) La Hulpe
    • Journal article
    Circulating DNA in the neoadjuvant setting of early stage colon cancer.
    Bregni, Giacomo Pretta, Andrea Senti, Chiara Acedo Reina, Elena Vandeputte, Caroline Trevisi, Elena Gkolfakis, Paraskevas Kehagias, Pashalina Deleporte, Amélie Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Deboever, Guido Janssens, Jos Demolin, Gauthier Holbrechts, Stephane Clausse, Marylene De Grez, Thierry Peeters, Marc D'Hondt, Lionel[UCL] Geboes, Karen Besse-Hammer, Tatiana Rothé, Françoise Flamen, Patrick Hendlisz, Alain Sclafani, Francesco (2022) Acta oncologica — Vol. 61, no. 10, p. 1223-1229 (2022)
    • Speech
    Weekly versus biweekly combination of docetaxel (d)-cisplatin (c)-5fu (f) in advanced gastric cancer and esogastric junction adenocarcinoma (agc): doge study
    Deleporte, Amélie Van den Eynde, Marc[UCL] Forget, F. Holbrechts, Stephane Delaunoit, Thierry Houbiers, Ghislain Kalantari, H. Rezaei Laurent, Stéphanie Vanderstraeten, Erik De Man, Marc Vergauwe, Philippe Clausse, Marylene Vanderauwera, J. Pierre, Pascal D'Hondt, Lionel[UCL] Ghillemijn, Bjorn Covas, Angélique Paesmans, Marianne Ameye, Lieveke Hendlisz, Alain (2014) 39th ESMO Congress (ESMO 2014) — (Spain) Madrid
    • Journal article
    Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.
    Deleporte, Amélie Van den Eynde, Marc[UCL] Forget, Frédéric Holbrechts, Stéphane Delaunoit, Thierry Houbiers, Ghislain Kalantari, Hassan R Laurent, Stéphanie Vanderstraeten, Erik De Man, Marc Vergauwe, Philippe Clausse, Marylene Van Der Auwera, Jacques D'Hondt, Lionel[UCL] Pierre, Pascal Ghillemijn, Bjorn Covas, Angelique Paesmans, Marianne Ameye, Lieveke Awada, Ahmad Sclafani, Francesco Hendlisz, Alain (2021) Cancer medicine — Vol. 10, no. 13, p. 4366-4374 (2021)
    • Journal article
    Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer
    Mardjuadi, Feby[UCL] Medioni, Jacques Kerger, Joseph[UCL] D'Hondt, Lionel[UCL] Canon, Jean-Luc Duck, Lionel Musuamba Tshinanu, Flora[UCL] Oudard, Stephane Clausse, Marylene Moxhon, Anne[UCL] Machiels, Jean-Pascal[UCL] (2012) Cancer Chemotherapy and Pharmacology — Vol. 70, no.2, p. 293-303 (2012)